Posts tagged “Quintiles”
In our latest wrapup of Triangle headlines from other publications, catch up on reports about the new Fortune 500 and what North Carolina firms made it as well as news about Time Warner Cable, Metabolon and an investigation into H-1B visas in Charlotte.
Triangle technology briefs: Quintiles launches a precision enrollment program for oncology trials; INC Research's veteran cahir and former CEO retires, and a current board member takes over; the CED is looking for startups who want to pitch investors at its annual venture capital event; and a new home care screening service launches in Raleigh.
Darrell Pryor, news photographer for WRAL TV, utters a "wow" and smiles as he removes the virtual reality goggles during the first VR demo given by Quintiles to news media about its new VR initiative. But Quintiles isn't playing games. It's aiming to improve the clinical trials process and digital health. "We feel we are out there at the edge," says the Quintiles exec leading the VR charge. "People come out of the experience different." Indeed, they do.
On International Clinical Trials day, Cynthia Verst, the president of Clinical Operations at Quintiles, writes that the use of secondary data earlier in the research process can lead to "smarter, faster and more cost-sensitive clinical trials."
In announcing the first four selections for the new Entrepreneur Hall of Fame, the Council for Entrepreneurial development also provides succinct biographies. Here they are - with photos.
The Council for Entrepreneurial Development's new Hall of Fame is kicking off with a powerful lineup of honorees: The father of venture capital in North Carolina, the co-founder of Quintiles, a longtime tech industry lawyer, and the irrepressible co-founder of Red Hat.
Three Wall Street firms have voted "no" on the big Quintiles-IMS Health merger so far by downgrading Quintiles stock. However, on Wednesday afternoon S&P Global Ratings weighed in with a positive review of the deal. WTW Insiders get the details.
Durham-based life science services giant Quintiles is merging with IMS Health Holdings in a deal forming a company worth some $17.6 billion. The merger was announced early Tuesday. Quintiles founder Dennis Gillings will lead the combined board but IMS shareholders will hold majority of stock. Wall Street, however, reacts negatively to the news.
The merger of Quintiles and IMS Health creating a $17 billion health services company announced Tuesday can be traced back to a meeting between the two CEOs last year. Quintiles' Tom Pike tells analysts the two firms discovered quickly how well they could work together, and the CEO of IMS says the collaboration has already delivered "major wins."
Tuesday's merger of Quintiles with IMS Health Services might trigger other CRO deals affecting the Triangle, says Chapel Hill-based analyst Andrew Schafer of Industry Standard Research. Also, Wall Street is giving the Q deal the thumbs down as shares tumble 8 percent. Why? Schafer explains. Plus, a Bloomberg columnist weighs in.
Any time companies merger, they talk about cost savings and "synergies." That often means layoffs with redundant services and more often being cut. So will there be an immediate impact in Durham at Quintiles' global headquarters? And why merge with IMS Health Services? WTW asks a Quintiles exec for details.
Quintiles is proposing to shut down a Phase 1 clinical trial unit in London which employs some 170 doctors and other staff, a company spokesperson tells WRAL TechWire.
Fortune's latest "Most Admired Companies" report includes Quintiles for the second straight year. IBM and AT&T crack the overall top 50, and Lenovo comes in at No. 3 among technology firms. Meanwhile, three "As" finished 1-2-3.
Quintiles reports quarterly earnings that top Wall Street expectations, and the business pipeline has CEO Tom Pike upbeat. "We believe we are well-positioned for the long-term with our $12.04 billion of backlog," he says.
In observance of Feb. 4 as "World Cancer Day," Terry Murdock, the head of the Oncology Center of Excellence at Quintiles, writes in a blog that "there is much to celebrate" this year in the fight against cancer.
With "apathetic" attitudes helping drive down life science industry stocks as part of a general market spiral, Quintiles CEO Tom Pike took to the airways Wednesday evening to defend his company and the biotech-related sector.
As digital health becomes more common in these days of emerging electronic medical records, wearable health devices and more, Quintiles is joining the growing number of companies seeking to capitalize on the world's biggest tech show: CES in Las Vegas. And Durham-based Validic exec will be leading the discussion in which Quintiles is participating.